Electrocardiographic abnormalities in patients with pulmonary sarcoidosis (RCD code: III)
Journal Title: Journal of Rare Cardiovascular Diseases - Year 2017, Vol 3, Issue 3
Abstract
Sarcoidosis is a systemic inflammatory disease characterized by the presence of noncaseating granulomas. Etiology of the disease remains unknown. From 3.7% to 54.9% patients with extra‑cardiac sarcoidosis have asymptomatic heart involvement. Conduction abnormalities, arrhythmias and congestive heart failure are the most common clinical manifestations of cardiac sarcoidosis (CS). The aim of the study was to evaluate the type and frequency of electrocardiographic abnormalities in patients with pulmonary sarcoidosis and to compare differences in the occurrence of electrocardiographic changes between patients diagnosed with CS and patients without confirmation of CS.Materials and methods: 49 patients (18 women, 31 men), mean age 45.6 ±12.2 years with biopsy‑proven pulmonary sarcoidosis were enrolled in the study. The patients were divided into two groups. Group 1 consisted of 12 patients diagnosed with CS, and Group 2 of 37 patients without diagnosis of CS. 12‑lead baseline electrocardiogram (ECG) was recorded for all participants.Results: 89.8% patients with pulmonary sarcoidosis had abnormal ECG. The most common ECG abnormalities were ST‑T changes observed in 79.6%. Conduction abnormalities were present in 26.5% of patients. 22.45% patients had left axis deviation. Rhythm abnormalities were recorded in 20.4% of all analyzed ECGs. ECGs of 8.16% of patients met criteria of hypertrophy. There was a trend towards more frequent prevalence of some ECG changes in patients with CS than patients without CS. However, these differences were not statistically significant.Conclusions: We observed a trend towards more frequent prevalence of some ECG abnormalities in a group of patients with CS than in patients without CS. However, these differences were not statistically significant. ECG abnormalities in patients with pulmonary sarcoidosis require further diagnostics. JRCD 2017; 3 (3): 81–85
Authors and Affiliations
Justyna Błaut-Jurkowska, Magdalena Kaźnica-Wiatr, Agnieszka Żygadło, Lidia Tomkiewicz- Pająk, Piotr Podolec, Maria Olszowska
Keywords
Related Articles
- EP ID EP242001
- DOI 10.20418/jrcd.vol3no3.266
- Views 123
- Downloads 0
Broad QRS complex tachycardia in a patient with myotonic dystrophy (Steinert disease) (RCD code: V‑4O)
Myotonic dystrophy is a rare inherited condition affecting primarily skeletal muscles and commonly associated with cardiovascular pathology. We report a case of a 50- year old female with myotonic dystrophy type 1 who pr...
3rd Symposium on Rare Cardiovascular Diseases – ESC Amsterdam 2013: Chairperson’s Perspective
The 3rd Satellite Symposiumon Rare Cardiovascular Diseases, which was organized by the Krakow Center for Rare Cardiovascular Diseases, was officially included in the Program of the 2013 ESC Congress and was held in the E...
The role of pharmacotherapy in the treatment of chronic thromboembolic pulmonary hypertension (RCD code: II-1A.5)
Chronic thromboembolic pulmonary hypertension (CTEPH) is a debilitating disease caused by chronic obstruction of major pulmonary arteries. The median age of patients at diagnosis of CTEPH is 63 years and both genders are...
The association between aortic stenosis and intestinal angiodysplasia – the Heyde’s Syndrome (RCD code: VIII-1)
Heyde’s syndrome is defined as a combination of gastrointestinal bleeding from a gastrointestinal angiodysplasia in patients with aortic stenosis. An acquired von Willebrand factor deficiency secondary to aortic stenosis...
“Join us in making voice of rare diseases heard” motto of the Rare Diseases Day, 29th February 2016
Just a few days ago, on 29th February we celebrated for the nine time the Rare Diseases Day. This year the main theme was “Patient Voice” as it is high time to recognize the crucial role of patients, their families and c...